Proportion of Active Substance-Based Prescriptions Out of Prescriptions Issued for Hypertensive Patients of All Risk Levels

Identifying Attributes

Care Settings
Primary Care
Country
Estonia
Publishing Organisation
Estonian Health Insurance Fund: Family Physicians Quality System Indicators
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Medications and Medication Management

Defining Attributes

Definition

The percentage of active substance-based prescriptions prescribed for insured patients in the family physicians' list with diagnoses I10 to I15 out of issued prescriptions.

Numerator

The number of hypertensive patients of all risk levels with an active substance-based prescription.

Denominator

All patients with all grades of severity who have been forwarded by the Health Insurance Fund in the current (reviewed) year, who are in the list of patients with chronical illnesses with a diagnosis of I10-I15 (ODC -10 codes) and who have been prescribed a medication with the hypertension medicines (clinical guideline).

Exclusions

The following cases are excluded; if according to the population register, the person has left Estonia (lives abroad) or the corresponding diagnosis of chronic illness is on the treatment invoice only with the extension "0 - diagnosis unspecified".

Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Collection and Reporting Attributes

Type of Data Collection
Administrative data
Data Collection Methods

Medical prescription database

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods

Reported by country on OECD. Stat stats.oecd.org/Index.aspx?QueryId=51881

Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Merilind et al. Pay for performance of Estonian family doctors and impact of different practice- and patient-related characteristics on a good outcome: A quantitative assessment

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025